Price Controls for Health Care?
In “The Price Is Right” (October 16), Peter Laakmann gives much-needed insight into why per capita spending on health care in the U.S., although higher than in other developed countries, is appropriate to our circumstances. However, he does not address why the price of health care is so high in the first place.
As a physician in Kentucky, I am amazed at the disparity between price and cost. A local lab bills the patient $125 for a blood test for which they bill me $4. When the FDA took generic colchicine off the market in 2010 in favor of Colcrys, its price jumped from $0.09 to $4.85 per tablet. When insurance companies began paying for CT scans to screen for lung cancer, the out-of-pocket price went from $175 to over $500.